Marker Therapeutics is trading 16.49% higher at $1.01 alongside a broad market rebound, though no company-specific catalyst was identified.
- No company-specific announcement dated November 9 was identified.
- The company’s investor-relations page lists an October 19 release as its latest press release.
- Reports say major U.S. indexes rose as investors bought shares after the prior week’s sell-off.